Leidos Holdings Derivative Gain (Loss) Excluded from Effectiveness decreased by 14.6% to -$55.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.2%, from -$49.00M to -$55.00M. Over 3 years (FY 2022 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows relatively stable performance with a 0.7% CAGR.
abbv_derivative_gain_loss_excluded_from_effectiveness| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$49.75M | -$49.75M | -$49.75M | -$49.75M | -$54.00M | -$56.00M | -$53.00M | -$49.00M | -$49.00M | -$51.00M | -$46.00M | -$47.00M | -$49.00M | -$55.00M | -$51.00M | -$48.00M | -$55.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -8.5% | -3.7% | +5.4% | +7.5% | +0.0% | -4.1% | +9.8% | -2.2% | -4.3% | -12.2% | +7.3% | +5.9% | -14.6% |
| YoY Change | — | — | — | — | -8.5% | -12.6% | -6.5% | +1.5% | +9.3% | +8.9% | +13.2% | +4.1% | +0.0% | -7.8% | -10.9% | -2.1% | -12.2% |